Mabel Catalán
Impact in
-
- Cardiac Fibrosis and Remodeling
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cell death mechanisms and regulation 4
- Mitochondrial Function and Pathology 4
- Signaling Pathways in Disease 3
-
- Cardiac Fibrosis and Remodeling 7
- Co-authors
- Raúl Vivar (16 shared papers)Ivonne Olmedo (11 shared papers)Guillermo Dı́az-Araya (12 shared papers)Sergio Lavandero (7 shared papers)Jorge Ferreira (6 shared papers)Claudio Humeres (7 shared papers)Pedro Ayala (6 shared papers)Lorena Garcı́a (4 shared papers)
- Journals
- Toxicology and Applied Pharmacology (4 papers)Cellular Signalling (4 papers)Toxicology in Vitro (3 papers)Advances in experimental medicine and biology (1 paper)Bioelectrochemistry (1 paper)
- Partner nations
- ChileUnited StatesUnited Kingdom
In The Last Decade
Mabel Catalán
26 papers receiving 364 citations
Peers
Comparison fields: 5 of 84
- Cardiology and Cardiovascular Medicine 98
- Cancer Research 53
- Molecular Biology 195
- Applied Microbiology and Biotechnology 5
- Aging 4
Countries citing papers authored by Mabel Catalán
This map shows the geographic impact of Mabel Catalán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mabel Catalán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mabel Catalán more than expected).
Fields of papers citing papers by Mabel Catalán
This network shows the impact of papers produced by Mabel Catalán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mabel Catalán. The network helps show where Mabel Catalán may publish in the future.
Co-authors
The 25 scholars most cited alongside Mabel Catalán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 45 | |
| 2 | 2011 | 36 | |
| 3 | 2020 | 27 | |
| 4 | 2016 | 24 | |
| 5 | 2020 | 24 | |
| 6 | 2020 | 21 | |
| 7 | 2012 | 21 | |
| 8 | 2010 | 19 | |
| 9 | 2014 | 18 | |
| 10 | 2012 | 17 | |
| 11 | 2013 | 15 | |
| 12 | 2020 | 15 | |
| 13 | 2012 | 14 | |
| 14 | 2021 | 13 | |
| 15 | 2020 | 12 | |
| 16 | 2023 | 9 | |
| 17 | 2022 | 6 | |
| 18 | 2019 | 6 | |
| 19 | 2023 | 5 | |
| 20 | 2024 | 4 |
About Mabel Catalán
Mabel Catalán is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Oncology and Organic Chemistry, having authored 27 papers that have together received 367 indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (7 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cell death mechanisms and regulation (4 papers), Mitochondrial Function and Pathology (4 papers), Peptidase Inhibition and Analysis (4 papers), Signaling Pathways in Disease (3 papers), Cardiac Ischemia and Reperfusion (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (98 citations), Cancer Research (53 citations), Molecular Biology (195 citations), Applied Microbiology and Biotechnology (5 citations) and Aging (4 citations). Mabel Catalán has collaborated with scholars based in Chile, United States and United Kingdom. Frequent co-authors include Raúl Vivar, Ivonne Olmedo, Guillermo Dı́az-Araya, Sergio Lavandero, Jorge Ferreira, Claudio Humeres, Pedro Ayala, Lorena Garcı́a, Catalina Carrasco‐Pozo and Pablo Aránguiz. Their work appears in journals such as Toxicology and Applied Pharmacology, Cellular Signalling, Toxicology in Vitro, Advances in experimental medicine and biology and Bioelectrochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.